[
  {
    "ts": null,
    "headline": "Citigroup Lawsuit Raises Questions For Long Term Culture And Returns",
    "summary": "A former Citigroup managing director has filed a lawsuit alleging sexual harassment by the bank's Head of Wealth, wrongful termination, and a hostile work environment. Citigroup is contesting the claims, seeking to move the case to arbitration, while the CEO has voiced confidence in the bank's internal investigation. The case places Citigroup's corporate culture, governance practices, and executive accountability under closer public and regulatory scrutiny. For investors watching NYSE:C,...",
    "url": "https://finnhub.io/api/news?id=0e516c32ffca43e1e67e1f85cac665386dbfeb821b388e7bf12b47bf7b9625ca",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769900912,
      "headline": "Citigroup Lawsuit Raises Questions For Long Term Culture And Returns",
      "id": 138319949,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "C",
      "source": "Yahoo",
      "summary": "A former Citigroup managing director has filed a lawsuit alleging sexual harassment by the bank's Head of Wealth, wrongful termination, and a hostile work environment. Citigroup is contesting the claims, seeking to move the case to arbitration, while the CEO has voiced confidence in the bank's internal investigation. The case places Citigroup's corporate culture, governance practices, and executive accountability under closer public and regulatory scrutiny. For investors watching NYSE:C,...",
      "url": "https://finnhub.io/api/news?id=0e516c32ffca43e1e67e1f85cac665386dbfeb821b388e7bf12b47bf7b9625ca"
    }
  },
  {
    "ts": null,
    "headline": "Citi Trims Progress Software (PRGS) PT to $54, Maintains Buy Rating",
    "summary": "Progress Software Corporation (NASDAQ:PRGS) is one of the best small cap tech stocks to invest in now. On January 16, as part of the firm’s 2026 infrastructure software outlook, Citi reduced its price target for Progress Software from $57 to $54 while maintaining a Buy rating. This adjustment came as the firm anticipates that the […]",
    "url": "https://finnhub.io/api/news?id=f35fe86d9d10ea543c5af549e934c75aead91f6899a2daaf38fbd635a5d190eb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769870705,
      "headline": "Citi Trims Progress Software (PRGS) PT to $54, Maintains Buy Rating",
      "id": 138315779,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "C",
      "source": "Yahoo",
      "summary": "Progress Software Corporation (NASDAQ:PRGS) is one of the best small cap tech stocks to invest in now. On January 16, as part of the firm’s 2026 infrastructure software outlook, Citi reduced its price target for Progress Software from $57 to $54 while maintaining a Buy rating. This adjustment came as the firm anticipates that the […]",
      "url": "https://finnhub.io/api/news?id=f35fe86d9d10ea543c5af549e934c75aead91f6899a2daaf38fbd635a5d190eb"
    }
  },
  {
    "ts": null,
    "headline": "Citi Sees a More Supportive Backdrop Forming for AbbVie (ABBV) and Biopharma",
    "summary": "AbbVie Inc. (NYSE:ABBV) is included among the 12 Best Stocks to Buy for the Long Term. On January 27, Citi modestly cut its price target on AbbVie Inc. (NYSE:ABBV) to $230 from $235 while leaving its Neutral rating unchanged. The adjustment was part of the firm’s broader Q4 review of the biopharma space. In its […]",
    "url": "https://finnhub.io/api/news?id=4b9735c3ac54bfdf754138cddcb6367e4f3144fa9028ce19dab6eeef9238fa0c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769866270,
      "headline": "Citi Sees a More Supportive Backdrop Forming for AbbVie (ABBV) and Biopharma",
      "id": 138315125,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "C",
      "source": "Yahoo",
      "summary": "AbbVie Inc. (NYSE:ABBV) is included among the 12 Best Stocks to Buy for the Long Term. On January 27, Citi modestly cut its price target on AbbVie Inc. (NYSE:ABBV) to $230 from $235 while leaving its Neutral rating unchanged. The adjustment was part of the firm’s broader Q4 review of the biopharma space. In its […]",
      "url": "https://finnhub.io/api/news?id=4b9735c3ac54bfdf754138cddcb6367e4f3144fa9028ce19dab6eeef9238fa0c"
    }
  },
  {
    "ts": null,
    "headline": "Alphabet, Amazon, AMD Lead Earnings Wave; Jobs Data On Deck",
    "summary": "Wall Street Week Ahead: key earnings (Amazon, Alphabet), IPOs, dividends & economic data (NFP, PMI). Read here for more details.",
    "url": "https://finnhub.io/api/news?id=b3e63802df6853657bf27d4f27978ea3f127e889b8b510bff3c097715be8804b",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769857200,
      "headline": "Alphabet, Amazon, AMD Lead Earnings Wave; Jobs Data On Deck",
      "id": 138315868,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "C",
      "source": "SeekingAlpha",
      "summary": "Wall Street Week Ahead: key earnings (Amazon, Alphabet), IPOs, dividends & economic data (NFP, PMI). Read here for more details.",
      "url": "https://finnhub.io/api/news?id=b3e63802df6853657bf27d4f27978ea3f127e889b8b510bff3c097715be8804b"
    }
  }
]